Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Angling Direct reports stronger-than-expected H1 trading performance

(Sharecast News) - Fishing tackle and equipment retailer Angling Direct reported a stronger-than-expected first-half trading performance on Wednesday, with revenues boosted by a solid UK performance. Angling Direct said it had delivered "a strong performance" in H126, with total revenue growth of 17.0% to £53.6m. Revenue in its UK business, both in store and online, was up 17.8% in Q2 as it maintained momentum from Q1 into the early months of its peak trading season.

Total UK like-for-like sales grew 14.2%, reflecting the strength of its omni-channel proposition and increasing customer reach, while outside the UK, its first European store in Utrecht saw customer store visits almost triple across June and July, and while the digital European market was said to have remained "challenging", total European sales were up 5.1% at £2.5m.

Net cash and equivalents sank 26.5% to £12.5m, due to Angling Direct's further investment in its UK store rollout and new digital "shelf edge" technology.

Chief executive Steve Crowe said: "Our increasing customer appeal, underpinned by our loyalty fishing club, MyAD, and the associated growth of revenues in our existing UK stores and digital platforms, provides us with further confidence in achieving our medium-term UK revenue target of £100m.

"We remain focused on delivering on our medium-term objectives and during H1 26 we executed further strategic and operational changes to deliver upon these. The board also remains confident that the group is comfortably trading in line with full-year consensus market expectations."

As of 0810 BST, Angling Direct shares were down 2.22% at 44p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.